Elucidating the properties of low-molecular-weight chromuim-binding substance

阐明低分子量铬结合物质的特性

• 批准号: 7268070
• 负责人: JOHN Bertram VINCENT
• 金额: $ 17.31万
• 依托单位: UNIVERSITY OF ALABAMA IN TUSCALOOSA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-08-01 至 2009-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7268070
• 关键词: Adjuvant Therapy; Animal Model; Binding; Biological; Cardiovascular Diseases; Cells; Chromium; Complex; Condition; Cyclotrons; Development; Diabetes Mellitus; Dose; Fourier Transform; Funding; Hypertension; Insulin; Insulin Receptor; Insulin Resistance; Ions; Kidney; Knowledge; Lead; Liver; Mass Spectrum Analysis; Methodology; Molecular; Molecular Weight; National Center for Complementary and Alternative Medicine; Nature; Non-Insulin-Dependent Diabetes Mellitus; Oligopeptides; Pathway interactions; Patients; Peptides; Personal Satisfaction; Pharmaceutical Preparations; Play; Procedures; Property; Role; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Symptoms; Testing; Time; Tissues; Urine; Work; diabetic; impaired glucose tolerance; in vivo; insulin sensitivity; insulin signaling; macromolecule; programs

DESCRIPTION (provided by applicant): Over 16 million people in the US have diabetes mellitus. Nearly 95% of these cases are of type 2 diabetes. Type 2 diabetes is responsible for the rapid increase in diabetes cases over the last few decades and is associated with insulin resistance. The body produces insulin normally (at least at first); however, the insulin signal is not properly transmitted into cells. Any mechanism by which insulin sensitivity might be enhanced has potential value in the treatment of symptoms of type 2 diabetes and other conditions related to insulin resistance (hypertension, cardiovascular disease, etc.). Chromium has been proposed to play a role in insulin signaling, and pharmacological doses of chromium have beneficial effects in diabetic patients and model animals. Understanding at a molecular level the role of chromium in insulin-signaling enhancement could lead to development of chromium-bsaed drugs for the treatment of diabetes. The importance of chromium was recently recognized by NCCAM through the funding program "Chromium as adjuvant therapy for type 2 diabetes and impaired glucose tolerance" (PA-01-114). Elucidating the role of chromium in enhancing insulin sensitivity has been hindered by a couple of experimental problems. First, the pathway by which chromium is distributed in the body has not been completely elucidated. Chromium in tissues such as liver and kidney is bound by the oligopeptide low-molecular weight chromium-binding substance (LMWCr) or chromodulin, which has been proposed to have a role in enhancing insulin signaling by interacting with insulin receptor. However, while LMWCR has been well characterized spectroscopically and magnetically, the oligopeptide has proven difficult to sequence and detect in biological matrices. The specific aims of this work are 1) to develop and utilize procedures for analyzing chromium-containing macromolecules by mass spectrometry, most notably highly acidic peptides and their Cr complexes including their fragmentation pathways, 2) to apply this knowledge to sequencing LMWCr (chromodulin) and related chromium-containing peptides, and 3) to determine the nature of the low-molar mass chromium-binding component of urine, postulated to be LMWCr. The approach will employ two advancing methodologies in mass spectrometry: electrospray ionization Fourier transform ion cyclotron resonance (ESI/FT-ICR) and matrix-assisted laser desorption ionization time-of-flight (MALDI/TOF).

描述（由申请人提供）：在美国有超过1600万人患有糖尿病。这些病例中近95%是2型糖尿病。在过去的几十年里，2型糖尿病是导致糖尿病病例迅速增加的原因，并且与胰岛素抵抗有关。身体正常分泌胰岛素（至少在开始时）；然而，胰岛素信号不能正确地传递到细胞中。任何可能增强胰岛素敏感性的机制在治疗2型糖尿病症状和其他与胰岛素抵抗相关的疾病（高血压、心血管疾病等）方面都有潜在价值。铬已被认为在胰岛素信号传导中发挥作用，药理剂量的铬对糖尿病患者和模型动物有有益的影响。在分子水平上理解铬在胰岛素信号增强中的作用可能会导致铬基糖尿病治疗药物的开发。最近，NCCAM通过资助项目“铬作为2型糖尿病和糖耐量受损的辅助治疗”（PA-01-114）认识到铬的重要性。阐明铬在提高胰岛素敏感性中的作用一直受到几个实验问题的阻碍。首先，铬在体内分布的途径尚未完全阐明。铬在肝、肾等组织中通过寡肽低分子量铬结合物质（low-molecular weight Chromium -binding substance, LMWCr）或铬调蛋白（chromodulin）结合，被认为通过与胰岛素受体相互作用增强胰岛素信号。然而，尽管LMWCR已经在光谱和磁性上得到了很好的表征，但在生物基质中，这种寡肽已被证明难以测序和检测。这项工作的具体目标是：1)开发和利用质谱法分析含铬大分子的方法，尤其是高酸性肽及其铬复合物，包括它们的断裂途径；2)将这些知识应用于低分子铬调节蛋白（chromodulin）和相关的含铬肽的测序；3)确定尿液中低摩尔质量铬结合成分的性质，假设是低分子铬结合成分。该方法将采用两种先进的质谱分析方法：电喷雾电离傅立叶变换离子回旋共振（ESI/FT-ICR）和基质辅助激光解吸电离飞行时间（MALDI/TOF）。

项目成果

Paramagnetic 19F NMR and Electrospray Ionization Mass Spectrometric Studies of Substituted Pyridine Complexes of Chromium(III): Models for Potential Use of 19F NMR to Probe Cr(III)-Nucleotide Interaction.

铬 (III) 取代吡啶配合物的顺磁 19F NMR 和电喷雾电离质谱研究：潜在使用 19F NMR 探测 Cr(III)-核苷酸相互作用的模型。

• DOI: 10.1016/j.poly.2013.03.002
• 发表时间: 2013
• 期刊: Polyhedron
• 影响因子: 2.6
• 作者: Rhodes,NicholasR;Belmore,Ken;Cassady,CarolynJ;Vincent,JohnB
• 通讯作者: Vincent,JohnB

Mass spectrometric and spectroscopic studies of the nutritional supplement chromium(III) nicotinate.

营养补充剂烟酸铬 (III) 的质谱和光谱研究。

• DOI: 10.1007/s12011-009-8319-8
• 发表时间: 2009
• 期刊: Biological trace element research
• 影响因子: 3.9
• 作者: Rhodes,NicholasR;Konovalova,Tatyana;Liang,Qiaoli;Cassady,CarolynJ;Vincent,JohnB
• 通讯作者: Vincent,JohnB

The effects of chromium(III) coordination on the dissociation of acidic peptides.

铬(III)配位对酸性肽解离的影响。

• DOI: 10.1002/jms.1374
• 发表时间: 2008
• 期刊: Journal of mass spectrometry : JMS
• 作者: Pu,Dan;Vincent,JohnB;Cassady,CarolynJ
• 通讯作者: Cassady,CarolynJ

Effects of transition metal ion coordination on the collision-induced dissociation of polyalanines.

• DOI: 10.1002/jms.1992
• 发表时间: 2011-11
• 期刊: Journal of mass spectrometry : JMS
• 作者: Heather M. Watson;J. Vincent;C. Cassady